로딩 중…
StockDiggingStockDigging

Quest Diagnostics Incorporated

DGX· NYSE
$232.01-0.43%
2026-08-03

Financials

Valuation Metrics

Quest Diagnostics Incorporated's Market Cap is $25.68B. At end of 2025 it was $19.00B. Ranked #519 of 3,112 in US market (top 17%), #366 of 1,667 on NYSE (top 22%), #34 of 206 in Health Care Equipment & Services (top 17%) by Market Cap.

Investment Metrics(as of 2026-08-03)

MetricValue
Size
Market Cap$25.68B
Revenue$11.56B
Net Income$1.06B
Total Assets$16.94B
Net Assets$7.52B
Employees46,000
Value
P/E24.18x
P/B3.42x
PEG1.79x
P/S2.22x
EV/EBITDA15.66x
FCF Yield4.75%
Profitability
ROE14.13%
ROA6.27%
Op. Margin14.14%
Revenue Growth10.21%
Earnings Growth13.48%
Financial Health
Debt Ratio121.34%
Total Debt$6.38B
FCF$1.22B
Cash$626M
Current Ratio1.59x
Net Debt/EBITDA2.87x
Dividend
Div. Yield1.41%
Div. Growth6.65%
Performance
1Y Return37.02%
1M Return7.55%
From 52W High-3.38%
1Y MDD-11.94%
Trading
Volume582,920 shares
Trading Value$135M
Per Share
EPS$8.94
BPS$64.59

Company Info

CEO Mr. James E. Davis
Employees 46,000
HQ Secaucus, United States

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.